Literature DB >> 17700344

Preference-based quality of life measures in people with visual impairment.

Steven M Kymes1, Bryan S Lee.   

Abstract

The use of preference-based measures of quality of life represents the application of principles of decision theory and welfare economics to the measurement of health-related concepts. In this Perspective, we present the theoretical basis of preference-based measures in the assessment of the impact of vision-related disease on quality of life and their role in cost-effectiveness analysis. We discuss the use of the standard gamble and time trade-off in eliciting utilities and the limitations of both methods. Scaling issues related to utility are discussed, in particular the reasons for use of the "policy scale" (i.e., a scale where utilities are anchored at 1.0 for perfect health and 0 as death). This is contrasted with the use of the "vision-truncated scale" (i.e., a scale with 1.0 representing perfect vision and 0 being death), which is commonly used in assessment of vision-related utilities. We discuss problematic aspects of using the truncated scale in conducting cost-effectiveness research for vision-related disease, and provide a theoretical and empirical discussion of these limitations. In particular, we point out how these results raise questions concerning the conceptual relationship between vision- and health-related quality of life. Finally, we present the results of previous cross-cultural and trans-national studies of vision-related quality of life to demonstrate how utility studies might provide insight into the meaning of disease across cultures.

Entities:  

Mesh:

Year:  2007        PMID: 17700344     DOI: 10.1097/OPX.0b013e3181337638

Source DB:  PubMed          Journal:  Optom Vis Sci        ISSN: 1040-5488            Impact factor:   1.973


  11 in total

Review 1.  Does coronary artery bypass grafting improve quality of life in elderly patients?

Authors:  Kamran Baig; Leanne Harling; Joseph Papanikitas; Saina Attaran; Hutan Ashrafian; Roberto Casula; Thanos Athanasiou
Journal:  Interact Cardiovasc Thorac Surg       Date:  2013-05-27

2.  Utility values in Japanese patients with exudative age-related macular degeneration.

Authors:  Yasuo Yanagi; Takashi Ueta; Ryo Obata; Aya Iriyama; Takashi Fukuda; Hideki Hashimoto
Journal:  Jpn J Ophthalmol       Date:  2011-02-18       Impact factor: 2.447

Review 3.  Challenges of Cost-Effectiveness Analyses of Novel Therapeutics for Inherited Retinal Diseases.

Authors:  K Thiran Jayasundera; Rebhi O Abuzaitoun; Gabrielle D Lacy; Maria Fernanda Abalem; Gregory M Saltzman; Thomas A Ciulla; Mark W Johnson
Journal:  Am J Ophthalmol       Date:  2021-08-22       Impact factor: 5.258

4.  Development of a preference-based index from the National Eye Institute Visual Function Questionnaire-25.

Authors:  Anne M Rentz; Jonathan W Kowalski; John G Walt; Ron D Hays; John E Brazier; Ren Yu; Paul Lee; Neil Bressler; Dennis A Revicki
Journal:  JAMA Ophthalmol       Date:  2014-03       Impact factor: 7.389

5.  Reducing older driver motor vehicle collisions via earlier cataract surgery.

Authors:  Stephen T Mennemeyer; Cynthia Owsley; Gerald McGwin
Journal:  Accid Anal Prev       Date:  2013-01-11

6.  Health-related quality of life following blind rehabilitation.

Authors:  Thomas Kuyk; Lei Liu; Jeffry L Elliott; Hartley E Grubbs; Cynthia Owsley; Gerald McGwin; Russell L Griffin; Patti S Fuhr
Journal:  Qual Life Res       Date:  2008-05       Impact factor: 4.147

7.  Preferences of diabetes patients and physicians: a feasibility study to identify the key indicators for appraisal of health care values.

Authors:  Franz Porzsolt; Johannes Clouth; Marc Deutschmann; Hans-J Hippler
Journal:  Health Qual Life Outcomes       Date:  2010-11-04       Impact factor: 3.186

Review 8.  How does age-related macular degeneration affect real-world visual ability and quality of life? A systematic review.

Authors:  Deanna J Taylor; Angharad E Hobby; Alison M Binns; David P Crabb
Journal:  BMJ Open       Date:  2016-12-02       Impact factor: 2.692

9.  Incremental cost-effectiveness of screening and laser treatment for diabetic retinopathy and macular edema in Malawi.

Authors:  Damir Vetrini; Christine A Kiire; Philip I Burgess; Simon P Harding; Petros C Kayange; Khumbo Kalua; Gerald Msukwa; Nicholas A V Beare; Jason Madan
Journal:  PLoS One       Date:  2018-01-04       Impact factor: 3.240

10.  Impact of Diabetic Retinopathy on Health-related Quality of Life in Iranian Diabetics.

Authors:  Cyrus Alinia; Seyed-Farzad Mohammadi; Alireza Lashay; Arash Rashidian
Journal:  Iran J Public Health       Date:  2017-01       Impact factor: 1.429

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.